tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GSK Stock Latest News

Sell Rating for GlaxoSmithKline Due to Limited Growth Prospects for Blenrep Amid Competitive Challenges and Regulatory Hurdles
RatingsSell Rating for GlaxoSmithKline Due to Limited Growth Prospects for Blenrep Amid Competitive Challenges and Regulatory Hurdles
1d ago
GSK
Sell Rating Issued for GlaxoSmithKline’s Blenrep Due to Restrictive Approval and Market Limitations
PremiumRatings
Sell Rating Issued for GlaxoSmithKline’s Blenrep Due to Restrictive Approval and Market Limitations
1d ago
GSK
GSK’s Blenrep approved by FDA for treatment of relapsed multiple myeloma
PremiumThe Fly
GSK’s Blenrep approved by FDA for treatment of relapsed multiple myeloma
2d ago
GSK
GSK’s New RSV Vaccine Study: A Potential Game-Changer for Investors
PremiumCompany Announcements
GSK’s New RSV Vaccine Study: A Potential Game-Changer for Investors
2d ago
GSK
Trump Trade: Trump administration prepares new probe into pharma prices
PremiumThe Fly
Trump Trade: Trump administration prepares new probe into pharma prices
3d ago
CI
AZN
GSK announces Phase III data from program to develop Ventolin
PremiumThe FlyGSK announces Phase III data from program to develop Ventolin
3d ago
GSK
Trump admin prepares new probe into U.S. pharma prices, FT says
Premium
The Fly
Trump admin prepares new probe into U.S. pharma prices, FT says
3d ago
CI
AZN
GSK announce EMA CHMP issued positive opinion for Shingrix in prefilled syringe
Premium
The Fly
GSK announce EMA CHMP issued positive opinion for Shingrix in prefilled syringe
4d ago
GSK
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
PremiumThe Fly
Spero Therapeutics, GSK announce PIVOT-PO trial efficacy and safety results
4d ago
GSK
SPRO
GSK treatment of malignant glioma designated for FDA orphan status
PremiumThe Fly
GSK treatment of malignant glioma designated for FDA orphan status
8d ago
GSK
ViiV Healthcare announces 96-week data from PASO DOBLE on Dovato
PremiumThe Fly
ViiV Healthcare announces 96-week data from PASO DOBLE on Dovato
8d ago
GSK
PFE
GSK’s Asthma Study Update: Potential Market Impacts
PremiumCompany Announcements
GSK’s Asthma Study Update: Potential Market Impacts
9d ago
GSK
Midday Fly By: Salesforce targets $60B in revenue, TSMC reports Q3 beat
PremiumThe FlyMidday Fly By: Salesforce targets $60B in revenue, TSMC reports Q3 beat
9d ago
C
BA
GSK CEO downplays role in leucovorin FDA effort, STAT reports
Premium
The Fly
GSK CEO downplays role in leucovorin FDA effort, STAT reports
9d ago
GSK
GSK’s RSV Vaccine Study Update: Promising Developments for Older Adults
Premium
Company Announcements
GSK’s RSV Vaccine Study Update: Promising Developments for Older Adults
11d ago
GSK
GSK’s NASH Study Completion: A Potential Game-Changer for Liver Disease Treatment
PremiumCompany Announcements
GSK’s NASH Study Completion: A Potential Game-Changer for Liver Disease Treatment
11d ago
GSK
GSK Advances Hepatitis B Treatment with Promising Study Update
PremiumCompany Announcements
GSK Advances Hepatitis B Treatment with Promising Study Update
11d ago
GSK
GSK’s Shingrix approved in China for prevention of shingles
PremiumThe Fly
GSK’s Shingrix approved in China for prevention of shingles
11d ago
GSK
Trump Weekly: Generics to be excluded from pharma tariff plan
PremiumThe Fly
Trump Weekly: Generics to be excluded from pharma tariff plan
15d ago
C
ES
Trump Trade: GoodRx, others in talks with White House to join TrumpRx
PremiumThe FlyTrump Trade: GoodRx, others in talks with White House to join TrumpRx
15d ago
AZN
BMY
GoodRx, others in talks with White House to join TrumpRx, Reuters reports
Premium
The Fly
GoodRx, others in talks with White House to join TrumpRx, Reuters reports
16d ago
AZN
BMY
Trump Trade: Generics to be excluded from pharma tariff plan
Premium
The Fly
Trump Trade: Generics to be excluded from pharma tariff plan
16d ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >